Literature DB >> 24853367

Correlation of contouring variation with modeled outcome for conformal non-small cell lung cancer radiotherapy.

Michael G Jameson1, Shivani Kumar2, Shalini K Vinod2, Peter E Metcalfe3, Lois C Holloway4.   

Abstract

BACKGROUND AND
PURPOSE: Contouring variation is a well know uncertainty in modern radiotherapy. This study investigates the relationship between contouring variation, tumor control probability (TCP) and equivalent uniform dose (EUD) for conformal non-small cell lung cancer (NSCLC) radiotherapy.
MATERIAL AND METHODS: Seven patients were retrospectively recruited to the study and multiple PTV contours were generated based on CT and PET imaging by three observers. Plans were created for each PTV volume. Volumes were analyzed geometrically using volume, location, dimension and conformity index (CI). Radiobiological plan analysis consisted of two TCP models and EUD. Spearman's correlation coefficient (ρ) was used to quantify the association between geometric variation and radiobiological metrics.
RESULTS: The variation in CI and TCP for the study was 0.66-0.90% and 0.19-0.68%. Changes in lateral dimension and volume were significantly correlated with TCP and EUD with an average ρ of -0.49 and 0.43 (p<0.01) respectively.
CONCLUSIONS: TCP and geometric contour variation show significant correlation. This correlation was most significant for changes in lateral dimensions of PTV volumes. This association may be used in the assessment of contouring protocol violations in multicenter clinical trials and aid in the design of future contouring studies. Crown
Copyright © 2014. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Contouring variation; EUD; Lung cancer; TCP

Mesh:

Substances:

Year:  2014        PMID: 24853367     DOI: 10.1016/j.radonc.2014.03.019

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  7 in total

1.  ACTIVE MEAN FIELDS FOR PROBABILISTIC IMAGE SEGMENTATION: CONNECTIONS WITH CHAN-VESE AND RUDIN-OSHER-FATEMI MODELS.

Authors:  Marc Niethammer; Kilian M Pohl; Firdaus Janoos; William M Wells
Journal:  SIAM J Imaging Sci       Date:  2017-07-27       Impact factor: 2.867

2.  Impact of dosimetric differences between CT and MRI derived target volumes for external beam cervical cancer radiotherapy.

Authors:  Vikneswary Batumalai; Siobhan Burke; Dale Roach; Karen Lim; Glen Dinsdale; Michael Jameson; Cesar Ochoa; Jacqueline Veera; Lois Holloway; Shalini Vinod
Journal:  Br J Radiol       Date:  2020-06-18       Impact factor: 3.039

Review 3.  Challenges in the target volume definition of lung cancer radiotherapy.

Authors:  Susan Mercieca; José S A Belderbos; Marcel van Herk
Journal:  Transl Lung Cancer Res       Date:  2021-04

4.  Introducing FDG PET/CT-guided chemoradiotherapy for stage III NSCLC in low- and middle-income countries: preliminary results from the IAEA PERTAIN trial.

Authors:  T Konert; W V Vogel; D Paez; A Polo; E Fidarova; H Carvalho; P S Duarte; A C Zuliani; A O Santos; D Altuhhova; L Karusoo; R Kapoor; A Sood; J Khader; A Al-Ibraheem; Y Numair; S Abubaker; C Soydal; T Kütük; T A Le; N X Canh; B Q Bieu; L N Ha; J S A Belderbos; M P MacManus; D Thorwarth; G G Hanna
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-07-31       Impact factor: 9.236

5.  Impact of Peer Review in the Radiation Treatment Planning Process: Experience of a Tertiary Care University Hospital in Pakistan.

Authors:  Bilal Mazhar Qureshi; Muhammad Atif Mansha; Muneeb Uddin Karim; Asim Hafiz; Nasir Ali; Benazir Mirkhan; Fatima Shaukat; Maria Tariq; Ahmed Nadeem Abbasi
Journal:  J Glob Oncol       Date:  2019-08

6.  Validation of an established deep learning auto-segmentation tool for cardiac substructures in 4D radiotherapy planning scans.

Authors:  Gerard M Walls; Valentina Giacometti; Aditya Apte; Maria Thor; Conor McCann; Gerard G Hanna; John O'Connor; Joseph O Deasy; Alan R Hounsell; Karl T Butterworth; Aidan J Cole; Suneil Jain; Conor K McGarry
Journal:  Phys Imaging Radiat Oncol       Date:  2022-07-26

Review 7.  Challenges for Quality Assurance of Target Volume Delineation in Clinical Trials.

Authors:  Amy Tien Yee Chang; Li Tee Tan; Simon Duke; Wai-Tong Ng
Journal:  Front Oncol       Date:  2017-09-25       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.